Literature DB >> 4064467

Interaction of ibuprofen with the H-2 receptor antagonists ranitidine and cimetidine.

H R Ochs, D J Greenblatt, R Matlis, J Weinbrenner.   

Abstract

The influences of cimetidine and ranitidine on single-dose ibuprofen kinetics were evaluated. Thirteen healthy subjects took a single, 600 mg oral dose of ibuprofen on three occasions: in the control state without drug coadministration; during concurrent dosing with cimetidine, 1.2 gm/day; and during concurrent dosing with ranitidine, 150 mg twice daily. Compared with the control state, cimetidine increased the peak serum ibuprofen concentration (64 vs. 56 micrograms/ml), but the value during ranitidine dosing (57 micrograms/ml) was indistinguishable from the control value. There were no significant differences between control, cimetidine, and ranitidine conditions in ibuprofen elimination t1/2 (2.1, 2.1, and 2.0 hours, respectively). Overall there was a significant difference among the control, cimetidine, and ranitidine conditions in ibuprofen oral clearance (52.8, 48.3, and 54.1 ml/min, respectively), but individual differences in cimetidine vs. control and between ranitidine vs. control were not statistically significant. The impairment of ibuprofen clearance by cimetidine is small, and ranitidine had no detectable effect on ibuprofen kinetics. These findings should be further validated during chronic dosing with ibuprofen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4064467     DOI: 10.1038/clpt.1985.239

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

Review 1.  Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues.

Authors:  J S Dixon; M C Page
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  A lack of pharmacokinetic interaction between ranitidine and piroxicam.

Authors:  J S Dixon; L F Lacey; M E Pickup; S J Langley; M C Page
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 4.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

5.  Lack of efficacy of cimetidine and ranitidine as inhibitors of tolbutamide metabolism.

Authors:  G I Adebayo; H A Coker
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Stereoselective disposition of ibuprofen enantiomers in infants.

Authors:  E Rey; A Pariente-Khayat; L Gouyet; F Vauzelle-Kervroëdan; G Pons; P D'Athis; M C Dubois; I Murat; C Lassale; M Goehrs
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

7.  Application of dual radiotelemetric technique in studying drug-drug interaction between diclofenac sodium and ranitidine HCl in volunteers.

Authors:  C Alioth; R A Blum; D T D'Andrea; G M Kochak; L Teng; B A Ziehmer; J J Schentag; K K Chan
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

Review 8.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 9.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 10.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.